Activity of NAD(P)H oxidase in relation to genotypes: comprehensive genetic mapping of single nucleotide polymorphisms (SNPs) in the p22(phox) subunit.
Hoffmann
M
M
Department of Clinical Pharmacology, University Medical Centre of the Georg-August-University, Göttingen, Germany.
Schirmer
M
M
Tzvetkov
M
M
Brockmoeller
J
J
D024509:3' Flanking Region / Q000235:genetics; D002874:Chromosome Mapping; D005189:False Positive Reactions; D015870:Gene Expression; D018740:Genetic Heterogeneity; D005838:Genotype; D006098:Granulocytes / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D006239:Haplotypes; D006801:Humans; D007438:Introns; D015810:Linkage Disequilibrium; D008562:Membrane Glycoproteins / Q000235:genetics / Q000378:metabolism*; D000074662:NADPH Oxidase 2; D019255:NADPH Oxidases / Q000235:genetics* / Q000378:metabolism*; D010641:Phenotype; D020641:Polymorphism, Single Nucleotide; D012333:RNA, Messenger / Q000235:genetics; D017382:Reactive Oxygen Species / Q000378:metabolism; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology
D008562:Membrane Glycoproteins; D012333:RNA, Messenger; D017382:Reactive Oxygen Species; C056558:CYBB protein, human; D000074662:NADPH Oxidase 2; D019255:NADPH Oxidases; C086986:CYBA protein, human; D013755:Tetradecanoylphorbol Acetate